Cargando…

[(18)F]fallypride characterization of striatal and extrastriatal D(2/3) receptors in Parkinson's disease

Parkinson's disease (PD) is characterized by widespread degeneration of monoaminergic (especially dopaminergic) networks, manifesting with a number of both motor and non-motor symptoms. Regional alterations to dopamine D(2/3) receptors in PD patients are documented in striatal and some extrastr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stark, Adam J., Smith, Christopher T., Petersen, Kalen J., Trujillo, Paula, van Wouwe, Nelleke C., Donahue, Manus J., Kessler, Robert M., Deutch, Ariel Y., Zald, David H., Claassen, Daniel O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849871/ https://www.ncbi.nlm.nih.gov/pubmed/29541577 http://dx.doi.org/10.1016/j.nicl.2018.02.010

Ejemplares similares

Lower (123)I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies
por: Joling, Merijn, et al.
Publicado: (2018)

Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An (123)I-FP-CIT SPECT study
por: Joling, Merijn, et al.
Publicado: (2019)

Striatal But Not Extrastriatal Dopamine Receptors Are Critical to Dopaminergic Motor Stimulation
por: Wang, Yuhan, et al.
Publicado: (2017)

Reduced D2/D3 Receptor Binding of Extrastriatal and Striatal Regions in Temporal Lobe Epilepsy
por: Bernedo Paredes, Viviane E., et al.
Publicado: (2015)

In vivo absolute quantification of striatal and extrastriatal D(2/3) receptors with [(123)I]epidepride SPECT
por: Tsartsalis, Stergios, et al.
Publicado: (2020)

Mapping the orbitofrontal cortex using temporal fluctuations in cerebral blood flow
por: Petersen, Kalen J., et al.
Publicado: (2021)

Multi-GBq production of the radiotracer [(18)F]fallypride in a droplet microreactor
por: Wang, Jia, et al.
Publicado: (2020)

Extrastriatal Dopaminergic Circuits of the Basal Ganglia
por: Rommelfanger, Karen S., et al.
Publicado: (2010)

Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson’s disease
por: Benazzouz, Abdelhamid, et al.
Publicado: (2014)

Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study
por: Marquie, Marta, et al.
Publicado: (2014)

Extrastriatal (123)I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Association between Striatal Subregions and Extrastriatal Regions in Dopamine D(1) Receptor Expression: A Positron Emission Tomography Study
por: Fujiwara, Hironobu, et al.
Publicado: (2012)

Exercise against cocaine sensitization in mice: a [(18)F]fallypride micro-PET study
por: Becker, Guillaume, et al.
Publicado: (2021)

Evaluation of the early response and mechanism of treatment of Parkinson's disease with L-dopa using (18)F-fallypride micro-positron emission tomography scanning
por: FA, YI-HUA, et al.
Publicado: (2016)

Taq1A polymorphism and medication effects on inhibitory action control in Parkinson disease
por: McDonell, Katherine E., et al.
Publicado: (2018)

No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder
por: Hernaus, D, et al.
Publicado: (2015)

Compensatory striatal–cerebellar connectivity in mild–moderate Parkinson's disease
por: Simioni, Alison C., et al.
Publicado: (2015)

Striatal shape alteration as a staging biomarker for Parkinson’s Disease()
por: Peralta, Maxime, et al.
Publicado: (2020)

Processing speed is related to striatal dopamine transporter availability in Parkinson's disease
por: Vriend, Chris, et al.
Publicado: (2020)

Chronic exposure to dopamine agonists affects the integrity of striatal D(2) receptors in Parkinson's patients
por: Politis, Marios, et al.
Publicado: (2017)

Cortical asymmetry in Parkinson's disease: early susceptibility of the left hemisphere
por: Claassen, Daniel O., et al.
Publicado: (2016)

Dopamine-induced changes to thalamic GABA concentration in impulsive Parkinson disease patients
por: Trujillo, Paula, et al.
Publicado: (2022)

Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: (18)F-Fallypride Positron Emission Tomography Study
por: Kuepper, Rebecca, et al.
Publicado: (2013)

Differences in Striatal Metabolism in [(18)F]FDG PET in Parkinson’s Disease and Atypical Parkinsonism
por: Seiffert, Alexander P., et al.
Publicado: (2022)

Self‐reported rates of impulsivity in Parkinson’s Disease
por: Aumann, Megan A., et al.
Publicado: (2020)

(18)F-fallypride and (11)C-methionine positron emission tomography/computed tomography for the study of prolactinomas and nonfunctioning pituitary adenomas: A case series
por: Damian, Andres, et al.
Publicado: (2021)

[(18)F]fallypride-PET/CT Analysis of the Dopamine D(2)/D(3) Receptor in the Hemiparkinsonian Rat Brain Following Intrastriatal Botulinum Neurotoxin A Injection
por: Mann, Teresa, et al.
Publicado: (2018)

Huntington disease exacerbates action impulses
por: Shiino, Shuhei, et al.
Publicado: (2023)

Striatal abnormalities in trichotillomania: A multi-site MRI analysis
por: Isobe, Masanori, et al.
Publicado: (2017)

COMT Val(158)Met Genotype Selectively Alters Prefrontal [(18)F]Fallypride Displacement and Subjective Feelings of Stress in Response to a Psychosocial Stress Challenge
por: Hernaus, Dennis, et al.
Publicado: (2013)

Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson’s Disease
por: Claassen, Daniel O., et al.
Publicado: (2016)

Data-driven identification of diagnostically useful extrastriatal signal in dopamine transporter SPECT using explainable AI
por: Nazari, Mahmood, et al.
Publicado: (2021)

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [(18)F] fluspidine and [(18)F] fallypride PET study
por: Grachev, Igor D., et al.
Publicado: (2020)

Diagnostic value of striatal (18)F-FP-DTBZ PET in Parkinson’s disease
por: Liu, Xiu-Lin, et al.
Publicado: (2022)

Fronto-striatal glutamate in children with Tourette's disorder and attention-deficit/hyperactivity disorder()
por: Naaijen, Jilly, et al.
Publicado: (2016)

Extrastriatal changes in patients with late-onset glutaric aciduria type I highlight the risk of long-term neurotoxicity
por: Boy, Nikolas, et al.
Publicado: (2017)

Increased ventral striatal functional connectivity in patients with schizophrenia during reward anticipation
por: Carruzzo, Fabien, et al.
Publicado: (2022)

The Relationships between Dopaminergic, Glutamatergic, and Cognitive Functioning in 22q11.2 Deletion Syndrome: A Cross-Sectional, Multimodal (1)H-MRS and (18)F-Fallypride PET Study
por: van Hooijdonk, Carmen F. M., et al.
Publicado: (2022)

Corrigendum: Diagnostic value of striatal (18)F-FP-DTBZ PET in Parkinson's disease
por: Liu, Xiu-Lin, et al.
Publicado: (2022)

Use of micro-positron emission tomography with (18)F-fallypride to measure the levels of dopamine receptor-D2 and (18)F-FDG as molecular imaging tracer in the pituitary glands and prolactinomas of Fischer-344 rats
por: Li, Ping, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f3f45kf1bqj6uql8sm57gt1mn6